Navigation Links
Urine Test Results Can Point to Heart Dangers
Date:11/20/2007

Presence of the protein albumin suggests worsening coronary artery disease, study finds

TUESDAY, Nov. 20 (HealthDay News) -- Even a small amount of a protein called albumin in the urine of patients with stable coronary artery disease increases their risk of cardiovascular death, say U.S. researchers.

The findings from this study of almost 3,000 patients, age 50 and older, with stable coronary artery disease (CAD) have implications for assessing and perhaps treating patients with vascular disease.

The study was published in the current issue of the journal Circulation.

Albumin is normal and necessary in blood, but its presence in urine indicates leakage in the kidney filtration system and possible damage to cells that line the kidney's blood vessels, according to background information in the study.

"We found that virtually any degree of albuminuria, even albumin below the level we call microalbuminuria, placed a patient at significantly higher risk of cardiovascular events," lead author Dr. Scott D. Solomon, associate professor of medicine at Harvard Medical School and director of Noninvasive Cardiology at Brigham and Women's Hospital in Boston, said in a prepared statement.

He and his colleagues also found that the hypertension drug trandolapril (an ACE inhibitor) lowered albumin levels in patients' urine.

The findings of this study and previous research by the same team indicate that "we cardiologists need to pay more attention to kidney function in our patients, and we need to look at two aspects -- filtration and albuminuria," Solomon said.

"It is important for cardiologists to understand that these are not patients who will even come to dialysis or even necessarily see a nephrologist," he said. "But they do have mild kidney disease that puts them at increased risk for a cardiovascular event."

More information

The U.S. National Institute of Diabete
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Human Urine Safe, Productive Fertilizer
2. Contamination from depleted uranium found in urine 20 years later
3. Haemacure Reports Third Quarter 2007 Results
4. Brooke Franchise Corporation Announces Selected July Results
5. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
6. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
7. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
8. NBTY Announces Preliminary Unaudited Net Sales Results For August 2007
9. Martek Announces Third Quarter 2007 Financial Results
10. MDS Reports Third Quarter 2007 Results
11. Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...Newswire-USNewswire/ -- Seabrook House, an interna... pleased to announce its plans for expanding their...ust a few of the ways Seabrook House is promotin...ible and that treatment works. Seabrook House,s vi... who needs it and to educate the public at large i...
(Date:1/7/2009)...swire/ -- A medical revolution emerges when,techn...l makes this connection,with its new Smart OR(TM)...ate-of-the-art treatment for neurosurgery, spine a...ewscom.com/cgi-bin/prnh/20081016/CLTH057 ) , ... technology, the Smart OR,helps neurosurgeons per...
(Date:1/7/2009)...in Regulatory Plans for Cutting-Edge Technology at...DC . , , WASHINGTON, Jan. 7 /PRNewswire-USNew...e than $60 billion in manufactured goods last year...By 2011, over $15 billion in nano-enabled drugs an...billion in 2006. And industry experts project that...
(Date:1/7/2009)...e-FirstCall/ -- Eli Lilly and Company,(NYSE: LL...urth quarter and,full year of 2008 on Thursday, J...rence call on that day with the investment communi...ncial performance. , The conference call wi...stors, media and the general public can access a l...
Breaking Medicine News(10 mins):Health News:Seabrook House Embraces the New Year with New Programs 2Health News:Seabrook House Embraces the New Year with New Programs 3Health News:A New, 'Smart' Approach to Brain and Spine Surgery 2Health News:A New, 'Smart' Approach to Brain and Spine Surgery 3Health News:Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy 2Health News:Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy 3Health News:Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy 4
...overnment and striking medicos continued today wit...d of setting up an experts committee// to review t...lso expected to meet Union Health Secretary P C Ho...esident doctors association of AIIMS made an appea...
...ancer survivors has revealed that most of these su...e as much compared// to those without a history of...ivors, those that have survived brain cancer or ot... a risk five times more pronounced of remaining jo...
...ed that, they are taking preventive steps with as ...past three months//. A senior health official ha...sit Tripura to assess the situation and to provide...rug resistance. He also stated that almost 200 te...
...44 % of women suffer from Intimate Partner Violenc...e mental health as well as the physical health of ...estigators of the Group Health Center for Health S...omen members. The researchers found that nearly ha...
Other Medicine News:
(Date:12/17/2008)...ANCISCO, Dec. 17 Medivat...it has completed patient enrollment in a,Phase 1-...ovel androgen,receptor antagonist, in castration-...ill seek approval from the U.S. Food and Drug Admi...rials next year. , The open-label, U.S. Pha...
(Date:12/17/2008)...ILLE, Calif., Dec. 17 Ne...: NTII ) today announced that an independent,Da...hat the current clinical,trials of Viprinex(TM) f...kely,to show benefit. As a result, the company ha...I will obtain and analyze the data before evaluati...
(Date:12/16/2008)...DA, Md., Dec. 16 Public...on reducing colon cancer deaths suggests a lower i...cian experts from the American College of Gastroen... that even if the assumptions and design of this c...onoscopy remains the best available option for det...
(Date:12/15/2008)...roadcast on December 18, 2008 at 9 a.m. Eastern Ti...re-FirstCall/ -- MannKind Corporation (Nasdaq: ...ical results from its final two Phase 3 studies of...aled insulin product, at 9 a.m. Eastern Time on Th...pate in the live call by telephone, please dial (8...
Breaking Medicine Technology:Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 3Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 4Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis 2Quality Colonoscopy Exam Remains Best Strategy for Detection of Polyps and Cancers According to Experts From the American College of Gastroenterology 2MannKind Corporation to Review Positive Results From Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes 2MedApps Wins Nokia 2008 Mobile Rules 21 Business Plan Competition Award 14870 1MedApps Wins Nokia 2008 Mobile Rules 21 Business Plan Competition Award 14870 2MedApps Wins Nokia 2008 Mobile Rules 21 Business Plan Competition Award 14870 3Plant gene clusters for natural products 2577 1Plant gene clusters for natural products 2577 2Iowa State researchers developing system to efficiently convert biomass to ethanol 4128 1Iowa State researchers developing system to efficiently convert biomass to ethanol 4128 2Iowa State researchers developing system to efficiently convert biomass to ethanol 4128 3ImaRx to Report Corporate Updates and 4Q07 Financial Results 4126 1ImaRx to Report Corporate Updates and 4Q07 Financial Results 4126 2
...4, 2007 /PRNewswire-FirstCall/ --,Bionovo, Inc.,s ...2,results for the treatment of hot flashes associa...n were enrolled in the company,s,double-blind, pla...nopausal women with 50 or more moderate to severe ...ee treatment groups receiving,MF101 (5 grams/day),...
... 2007 /PRNewswire-FirstCall/ -- VION,PHARMACEUTICA...cal,data in a poster session at the 43rd Annual Me... (ASCO) on its lead anticancer agent,Cloretazine(R...l in,patients with relapsed or refractory small ce...retazine(R) (VNP40101M) in two,separate subpopulat...
Other Medicine Technology:Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 2Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 3Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 4Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 5Vion Pharmaceuticals Presents Updated Clinical Data from a Phase II,trial of Cloretazine (VNP40101M) in Patients with Relapsed or,Refractory Small Cell Lung Cancer 2Vion Pharmaceuticals Presents Updated Clinical Data from a Phase II,trial of Cloretazine (VNP40101M) in Patients with Relapsed or,Refractory Small Cell Lung Cancer 3Vion Pharmaceuticals Presents Updated Clinical Data from a Phase II,trial of Cloretazine (VNP40101M) in Patients with Relapsed or,Refractory Small Cell Lung Cancer 4
... Biotech Captia™ Mumps IgG Enzyme- linked Immu...ion and quantitative determination of IgG antibody...ecimens may be used for the determination of immun... be used to demonstrate seroconversion or a signif...
The DSL 05-10-MUM Mumps IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Mumps virus in human serum. This assay is intended for in
...tem is comprised of the TEG analyzer and the TEG a...ete picture of the formation and dissolution of th...o systems. ,Haemoscope's TEG analyzer is the onl... follows the reliable and proven model developed b...
... treatment of diseases of the thoracic aorta has i...on in the chest to place a synthetic graft to repa...long hospital stays and painful recoveries. Today,...ternatives to this major open surgical approach.,...
Medicine Products: